Peer Review History: Advancements in Tyrosine Kinase Inhibitors Therapy: Role of Imatinib, the First Targeted Treatment for Chronic Myeloid Leukemia

Editor(s):

(1) Prof. Maged Refaat, Ain Shams University, Egypt.

Approved by:

(1) Dr. Sinan Ince, Associate Professor, Afyon Kocatepe University, Turkey.

Reviewers:

(1) Praphull Deepankar, Indira Gandhi Institute of Medicine Sciences, India.

(2) Pilar Giraldo, Hospital Quironsalud, Spain.

Additional Reviewers:

Additional Reviewers: (Comments received after deadline)

Peer Review History:

Peer Review Report_1 (Praphull Deepankar, India) | File 1 | NA

Peer Review Report_2 (Pilar Giraldo, Spain) | File 1 | File 2

Comment_Academic_Editor | File 1 | NA

Comment_Book_Editor | File 1 | NA